AKT1 and colorectal cancer: The reasons for these findings, which are opposite those of previously reported outcomes, are attributed to PI3K and AKT consistently taking an active part in promoting tumour cell progression; however, the literature indicates that the expression of PI3K, AKT and FOXO3a is reduced by miR-493-5p, which is an oncogene that promotes the growth of colorectal cancer cells.